In this article we will explore in depth what we know so far about this new variant: the symptoms, how it emerged and its implications. Additionally, we will provide advice backed by our team of specialists. Keep reading and learn more about JN.1, the new Covid-19 variant.
How did this variant arise and what does it mean Ibruxen 140 mg (Ibrutinib) for it to be a variant of interest?
Variants of a virus, such as SARS-CoV-2 that causes COVID-19, can emerge as the virus replicates and spreads. The JN.1 variant, identified for the first time in the United States at the end of August 2023. However, according to the World Health Organization (WHO) , JN.1 was previously part of BA.2.86, a subvariant of Omicron . However, due to its rapid spread, the WHO classifies it as a variant of concern separate from BA.2.86.
When a variant is detected that could have important implications, public health experts and epidemiologists classify it as a “variant of concern.” Likewise, according to the CDC classification, the variants of interest have the following characteristics:
Increase in the percentage of disease transmission.
Less response to treatments.
Greater ability to evade existing immunity generated by previous infection or vaccines.
You may be interested in: Covid-19 consequences, how to recognize them?
Reinfection: How does the new JN.1 variant affect people who have already had Covid-19 and recovered?
Variants of the SARS-CoV-2 virus, including the JN.1 Pirola variant, can affect people who have already had COVID-19 and are fully recovered. The new Covid-19 variant contains mutations that affect the immune system's ability to recognize and defend against the virus. This increases the risk of reinfection, compared to other variants.